Factors predicting prognosis and recurrence in patients with esophago-gastric adenocarcinoma and histopathological response with less than 10 % residual tumor
作者： Katja Ott , Susanne Blank , Karen Becker , Rupert Langer , Wilko Weichert
DOI: 10.1007/S00423-012-1039-0
关键词:
摘要: Purpose Neoadjuvant treatment is an accepted standard approach for treating locally advanced esophago-gastric adenocarcinomas. Despite a response of the primary tumor, significant percentage dies from tumor recurrence. The aim this retrospective exploratory study two academic centers was to identify predictors survival and recurrence in histopathologically responding patients.
springer.com
core.ac.uk
sci-hub.se 参考文章(35)
Karen Becker, Rupert Langer, Daniel Reim, Alexander Novotny, Christian Meyer zum Buschenfelde, Jutta Engel, Helmut Friess, Heinz Hofler, Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases. Annals of Surgery. ,vol. 253, pp. 934- 939 ,(2011) , 10.1097/SLA.0B013E318216F449
Paul M. Schneider, Stephan E. Baldus, Ralf Metzger, Martin Kocher, Rudolf Bongartz, Elfriede Bollschweiler, Hartmut Schaefer, Juergen Thiele, Hans P. Dienes, Rolf P. Mueller, Arnulf H. Hoelscher, Histomorphologic Tumor Regression and Lymph Node Metastases Determine Prognosis Following Neoadjuvant Radiochemotherapy for Esophageal Cancer: Implications for Response Classification Annals of Surgery. ,vol. 242, pp. 684- 692 ,(2005) , 10.1097/01.SLA.0000186170.38348.7B
Katja Ott, Andreas Sendler, Karen Becker, Hans-Joachim Dittler, Hermann Helmberger, Raimonde Busch, Christian Kollmannsberger, J. R�diger Siewert, Ulrich Fink, Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study Gastric Cancer. ,vol. 6, pp. 159- 167 ,(2003) , 10.1007/S10120-003-0245-4
Sylvie Lorenzen, Susanne Blank, Florian Lordick, Jörg-Rüdiger Siewert, Katja Ott, Prediction of Response and Prognosis by a Score Including Only Pretherapeutic Parameters in 410 Neoadjuvant Treated Gastric Cancer Patients Annals of Surgical Oncology. ,vol. 19, pp. 2119- 2127 ,(2012) , 10.1245/S10434-012-2254-1
Wolfgang A. Weber, Katja Ott, Karen Becker, Hans-Joachim Dittler, Hermann Helmberger, Norbert E. Avril, Günther Meisetschläger, Raymonde Busch, Jörg-Rüdiger Siewert, Markus Schwaiger, Ulrich Fink, Prediction of Response to Preoperative Chemotherapy in Adenocarcinomas of the Esophagogastric Junction by Metabolic Imaging Journal of Clinical Oncology. ,vol. 19, pp. 3058- 3065 ,(2001) , 10.1200/JCO.2001.19.12.3058
Michael J. Overman, Syed M. Kazmi, Jagriti Jhamb, E Lin, James C. Yao, James L. Abbruzzese, Linus Ho, Jaffer Ajani, Alexandria Phan, Weekly docetaxel, cisplatin, and 5‐fluorouracil as initial therapy for patients with advanced gastric and esophageal cancer Cancer. ,vol. 116, pp. 1446- 1453 ,(2010) , 10.1002/CNCR.24925
R C Fields, V E Strong, M Gönen, K A Goodman, N P Rizk, D P Kelsen, D H Ilson, L H Tang, M F Brennan, D G Coit, M A Shah, Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma. British Journal of Cancer. ,vol. 104, pp. 1840- 1847 ,(2011) , 10.1038/BJC.2011.175
Pooja Rohatgi, Stephen G. Swisher, Arlene M. Correa, Tsung-T. Wu, Zhongxing Liao, Ritsuko Komaki, Garrett L. Walsh, Ara A. Vaporciyan, David C. Rice, Jack A. Roth, Jaffer A. Ajani, Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response Cancer. ,vol. 104, pp. 2365- 2372 ,(2005) , 10.1002/CNCR.21439
U. Fink, C. Schuhmacher, H. J. Stein, R. Busch, H. Feussner, H. J. Dittler, A. Helmberger, K. Böttcher, J. R. Siewert, Preoperative chemotherapy for stage III–IV gastric carcinoma: Feasibility, response and outcome after complete resection British Journal of Surgery. ,vol. 82, pp. 1248- 1252 ,(2005) , 10.1002/BJS.1800820930
Andrew M. Lowy, Paul F. Mansfield, Steven D. Leach, Richard Pazdur, Pamela Dumas, Jaffer A. Ajani, Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer. Annals of Surgery. ,vol. 229, pp. 303- 308 ,(1999) , 10.1097/00000658-199903000-00001